NCT06997887

Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: National Taiwan University Hospital · Academic / Other
• Sex: Female
• Age: 20 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index scores.

Detailed description

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index (FSFI) scores. Follow-up assessments will be conducted to determine whether CH2 vaginal gel or vaginal rehabilitation can improve post-radiotherapy vaginal health and enhance the long-term quality of life for women with cancer.

Conditions

• Gynecologic Malignancy

Interventions

Type	Name	Description
OTHER	CH2 vaginal gel	12-week intervention with CH2 vaginal gel
OTHER	vaginal rehabilitation exercises	12-week intervention with vaginal rehabilitation exercises

Timeline

• Start date: 2025-05-09
• Primary completion: 2028-05-09
• Completion: 2030-05-09
• First posted: 2025-05-31
• Last updated: 2025-06-27

Locations

1 site across 1 country: Taiwan